The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
kang zhong liu yao enzalutamide
Pages: 777-778
Year: Issue:  12
Journal: World Clinical Drugs

Keyword:  抗肿瘤药Enzalutamide商品名前列腺癌患者制药公司活性代谢物雄激素受体安慰剂药动学血浆蛋白结合率;
Abstract: <正>1商品名Xtandi2开发与上市厂商本品由美国Medivation制药公司和日本安斯泰来制药公司(Astellas Pharma Inc.)共同开发,2012年8月获FDA批准,2012年9月在美国首次上市。3适应证本品适用于经多西他赛治疗无效的转移性去势耐受性前列腺癌患者。
Related Articles
No related articles found